Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessandro Bergamasco
Institution:
University of Bari Aldo Moro
Observed institution:
University of Bari Aldo Moro
ORCID:
0009-0008-6387-0560
Observed ORCID:
0009-0008-6387-0560
OpenAlex ID:
A5081893645
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
2024
·
Sara Volpe
, Alfredo Vozza
, et al.
·
Nutrients
·
27
Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
2022
·
Giuseppina Piazzolla
, Alfredo Vozza
, et al.
·
Open Medicine
·
11
PDF
Glucagon‐Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26‐Week Prospective Observational Real‐Life Study
2025
·
Alfredo Vozza
, Sara Volpe
, et al.
·
Journal of Diabetes Research
·
9
PDF
Show more works
View as search
Works count:
3
Citation count:
47
H-index:
3
I10-index:
2
Year
Topic
Type